Research study Program year 2023 Source: CMS Open Payments

Phase III Long Term Roll Over Psoriasis

Research payments

$528,891

17 payments

Through program year 2023, $528,891 in research payments was reported against Phase III Long Term Roll Over Psoriasis, across 17 payments, paid by E.R. Squibb & Sons, L.L.C..

Paid by: E.R. Squibb & Sons, L.L.C.
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2023	Research	$420,455	6
2022	Research	$77	1
2019	Research	$108,360	10

Breakdown

Who paid Research payments · program years 2019–2023

E.R. Squibb & Sons, L.L.C. $528,891 17 payments

Who received the money Research payments · program years 2019–2023

Dermatology Research Associates - Los Angeles Organisation paid for research $241,427 1 payment
La Universal Research Center Organisation paid for research $150,628 1 payment
Clinical Research Advantage, Incorporated Organisation paid for research $77,935 5 payments
San Marcus Research Clinic Organisation paid for research $14,450 1 payment
Well Pharma Medical Research Organisation paid for research $9,031 1 payment
Springfield Clinic, LLP Organisation paid for research $7,000 1 payment
Beacon Clinical Research Organisation paid for research $6,525 1 payment
Advanced Clinical Research Incorporated Organisation paid for research $5,750 1 payment
Oregon Dermatology And Research Center Organisation paid for research $5,650 1 payment
Wilmington Dermatology Center Organisation paid for research $5,500 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.